Your browser doesn't support javascript.
loading
Physiological Assessment with iFR prior to FFR Measurement in Left Main Disease.
Warisawa, Takayuki; Cook, Christopher M; Ahmad, Yousif; Howard, James P; Seligman, Henry; Rajkumar, Christopher; Toya, Takumi; Doi, Shunichi; Nakajima, Akihiro; Nakayama, Masafumi; Vera-Urquiza, Rafael; Yuasa, Sonoka; Sato, Takao; Kikuta, Yuetsu; Kawase, Yoshiaki; Nishina, Hidetaka; Al-Lamee, Rasha; Sen, Sayan; Lerman, Amir; Matsuo, Hitoshi; Akashi, Yoshihiro J; Escaned, Javier; Davies, Justin E.
Afiliación
  • Warisawa T; Department of Cardiology, St. Marianna University School of Medicine, 2-16-1 Sugao, Kawasaki, 216-8511, Japan. warisawa-tky@umin.ac.jp.
  • Cook CM; Department of Cardiology, NTT Medical Center Tokyo, Tokyo, Japan. warisawa-tky@umin.ac.jp.
  • Ahmad Y; National Heart and Lung Institute, Imperial College London, London, UK. warisawa-tky@umin.ac.jp.
  • Howard JP; The Essex Cardiothroacic Centre, Essex, UK.
  • Seligman H; Anglia Ruskin University, Essex, UK.
  • Rajkumar C; Cardiovascular Medicine, Yale School of Medicine, New Haven, USA.
  • Toya T; National Heart and Lung Institute, Imperial College London, London, UK.
  • Doi S; Cardiovascular Science, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK.
  • Nakajima A; National Heart and Lung Institute, Imperial College London, London, UK.
  • Nakayama M; Guys and St, Royal Brompton and Harefield Hospitals, Thomas NHS Foundation Trust, London, UK.
  • Vera-Urquiza R; National Heart and Lung Institute, Imperial College London, London, UK.
  • Yuasa S; Cardiovascular Science, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK.
  • Sato T; Department of Cardiology, National Defense Medical College, Tokorozawa, Japan.
  • Kikuta Y; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, USA.
  • Kawase Y; Department of Cardiology, St. Marianna University School of Medicine, 2-16-1 Sugao, Kawasaki, 216-8511, Japan.
  • Nishina H; Department of Cardiovascular Medicine, New Tokyo Hospital, Matsudo, Japan.
  • Al-Lamee R; Department of Cardiology, Tokyo D Tower Hospital, Tokyo, Japan.
  • Sen S; Cardiovascular Center, Toda Central General Hospital, Toda, Japan.
  • Lerman A; Hospital Clinico San Carlos IDISSC, Complutense University of Madrid, Madrid, Spain.
  • Matsuo H; Hospital Clinico San Carlos IDISSC, Complutense University of Madrid, Madrid, Spain.
  • Akashi YJ; Department of Cardiology, Tachikawa General Hospital, Nagaoka, Japan.
  • Escaned J; National Heart and Lung Institute, Imperial College London, London, UK.
  • Davies JE; Division of Cardiology, Fukuyama Cardiovascular Hospital, Fukuyama, Japan.
Cardiovasc Interv Ther ; 39(3): 241-251, 2024 Jul.
Article en En | MEDLINE | ID: mdl-38642290
ABSTRACT
Despite guideline-based recommendation of the interchangeable use of instantaneous wave-free ratio (iFR) and fractional flow reserve (FFR) to guide revascularization decision-making, iFR/FFR could demonstrate different physiological or clinical outcomes in some specific patient or lesion subsets. Therefore, we sought to investigate the impact of difference between iFR and FFR-guided revascularization decision-making on clinical outcomes in patients with left main disease (LMD). In this international multicenter registry of LMD with physiological interrogation, we identified 275 patients in whom physiological assessment was performed with both iFR/FFR. Major adverse cardiovascular event (MACE) was defined as a composite of death, non-fatal myocardial infarction, and ischemia-driven target lesion revascularization. The receiver-operating characteristic analysis was performed for both iFR/FFR to predict MACE in respective patients in whom revascularization was deferred and performed. In 153 patients of revascularization deferral, MACE occurred in 17.0% patients. The optimal cut-off values of iFR and FFR to predict MACE were 0.88 (specificity0.74; sensitivity0.65) and 0.76 (specificity0.81; sensitivity0.46), respectively. The area under the curve (AUC) was significantly higher for iFR than FFR (0.74; 95%CI 0.62-0.85 vs. 0.62; 95%CI 0.48-0.75; p = 0.012). In 122 patients of coronary revascularization, MACE occurred in 13.1% patients. The optimal cut-off values of iFR and FFR were 0.92 (specificity0.93; sensitivity0.25) and 0.81 (specificity0.047; sensitivity1.00), respectively. The AUCs were not significantly different between iFR and FFR (0.57; 95%CI 0.40-0.73 vs. 0.46; 95%CI 0.31-0.61; p = 0.43). While neither baseline iFR nor FFR was predictive of MACE in patients in whom revascularization was performed, iFR-guided deferral seemed to be safer than FFR-guided deferral.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad de la Arteria Coronaria / Reserva del Flujo Fraccional Miocárdico Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cardiovasc Interv Ther Año: 2024 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Japón

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad de la Arteria Coronaria / Reserva del Flujo Fraccional Miocárdico Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cardiovasc Interv Ther Año: 2024 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Japón